TPX2 and cancer: A recent study showed that aurora A kinase and the targeting protein for Xklp2 (TPX2) are novel co-regulators of the MYC pathway, suggesting that targeting of the aurora A kinase/TPX2 axis could be a therapeutic approach for MYC-driven cancers [34].